Germany CAR-T Cell Therapy Market, By Region, Competition, Forecast and Opportunities, 2018-2028F

By Tumor Type (Hematological Malignancies, Solid Tumors), By Indication (Diffused Large B-Cell Lymphoma (DLBCL), Acute Lymphoblastic Leukemia (ALL), Follicular Lymphoma (FL), Mantle Cell Lymphoma (MCL), Others), By Treatment Type (Single Treatment, Combination Treatment), By Targeted Antigen (CD 19, BCMA (B-Cell Maturation Antigen), Others), By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others) Region and Competition, Opportunity, and Forecast, 2018-2028

Published	Pages	Publisher	Report code
Nov 2023	81	TechSci Research	ASDR-641540

Published: Nov 2023 - Pages : 81 - Publisher : TechSci Research - Report code : ASDR-641540

1. Gilead Sciences
Inc
2. Novartis International AG
3. Bristol Myers Squibb Co.
4. AbbVie Inc.
5. Cellectis SA
6. Amgen Inc
7. Pfizer Inc.
8. Merck & Co. Inc.
9. Intellia Therapeutics Inc.
10. Poseida Therapeutics Inc

Germany CAR-T Cell Therapy Market, By Region, Competition, Forecast and Opportunities, 2018-2028F

How can I help you?

Purchase this report

This report can be of interest as well:

Current Research and Development Status of Chimeric Antigen Receptor (CAR) T-Cell Therapy Market

Cell Therapy Market Research

Germany CAR-T Cell Therapy Market, By Region, Competition, Forecast and Opportunities, 2018-2028F

How can I help you?

Purchase this report

This report can be of interest as well:

Current Research and Development Status of Chimeric Antigen Receptor (CAR) T-Cell Therapy Market